Helsinn and Lyfebulb Announce Call for Applications for Third Annual Patient-Driven Innovation Summit & Award in Oncology 17 September 2019
Helsinn and Mundipharma China Pharmaceutical jointly announce NMPA’s approval of the oral formulation of Akynzeo® in China 16 September 2019
APR presents new data at SSIEM Annual Symposium showing benefits of PKU GOLIKE® in PKU management 4 September 2019
Helsinn signs exclusive distribution and license agreements with Blanver and Varifarma for Pracinostat in South America 2 September 2019
Helsinn and Lyfebulb Announce Third Annual Patient-Driven Innovation Summit & Award in Oncology to be held during the 14th Monaco Biennale of Oncology 2020 30 August 2019
Helsinn and Endo Announce Agreement for Paladin Labs Inc. to Commercialize Pracinostat in Canada 31 July 2019
Helsinn appoints Giorgio Calderari, Group General Manager and Chief Operating Officer, to the Board of Directors 26 June 2019
Linkedin